The impact of omeprazole on mycophenolate pharmacokinetics in kidney transplant recipients.
Mohamed S.AbdElhalimAhmed KenawyHeba DemellawyAmany A AzouzSarah S AlghanemTorki Al-OtaibiOsama Ashry GheithMohamed AbdelMonemmohammed afifiRaghda R S HusseinPublished in: Kidney research and clinical practice (2020)
Omeprazole can be safely co-administered with either MMF or EC-MPS, as it did not compromise the MPA exposure. Unexpectedly, however, a high percentage of patients presented MPA AUCs exceeding the target value, highlighting the importance of periodically assessing MPA level.
Keyphrases